Efficacy & Safety of Olmesartan Associated With Chlorthalidone in

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02521233` - Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control	Phase 3
Withdrawn	`NCT02521246` - Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control	Phase 3
Completed	`NCT04927299` - Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension	Phase 3

See also

Status

Clinical Trial

Phase

Withdrawn

NCT02521233 - Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

Phase 3

Withdrawn

NCT02521246 - Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control

Phase 3

Completed

NCT04927299 - Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02493322
Study type	Interventional
Source	EMS
Contact	Monalisa F.B. Oliveira, M.D.
Phone	+551938879851
Email	pesquisa.clinica@ems.com.br
Status	Not yet recruiting
Phase	Phase 3
Start date	December 2024
Completion date	November 2026

Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms